相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Silencing the YB-1 Gene Inhibits Cell Migration in Gastric Cancer In Vitro
Tian Tian Guo et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2013)
YB-1: oncoprotein, prognostic marker and therapeutic target?
Annette Lasham et al.
BIOCHEMICAL JOURNAL (2013)
Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma
Y. Fujiwara-Okada et al.
BRITISH JOURNAL OF CANCER (2013)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
被撤回的出版物: MIG-7 Controls COX-2/PGE2-Mediated Lung Cancer Metastasis (Retracted article. See vol. 79, pg. 4553, 2019)
Ming-Yi Ho et al.
CANCER RESEARCH (2013)
ERK and RSK regulate distinct steps of a cellular program that induces transition from multicellular epithelium to single cell phenotype
Josef Caslavsky et al.
CELLULAR SIGNALLING (2013)
Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression
Juan Ma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Prostaglandin E2 receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells
Xiaoming Bai et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cells
Bo Sun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells
Michele B. Weiss et al.
CANCER RESEARCH (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections
Jimmy K. Stauffer et al.
HEPATOLOGY (2012)
Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced gastric cancer
Ying Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
YB-1, the E2F Pathway, and Regulation of Tumor Cell Growth
Annette Lasham et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model
Xiping Xin et al.
LABORATORY INVESTIGATION (2012)
E series prostaglandins alter the proliferative, apoptotic and migratory properties of T98G human glioma cells in vitro
Renata N. Gomes et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
YB-1 alters MT1-MMP trafficking and stimulates MCF-7 breast tumor invasion and metastasis
David H. Lovett et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Cyclooxygenase-2 enhances α2β1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells
Ju-Fang Liu et al.
MOLECULAR CANCER (2010)
Deconstructing ERK Signaling in Tumorigenesis
Patricia G. Santamaria et al.
MOLECULAR CELL (2010)
Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells
Xiao-Ming Bai et al.
LIFE SCIENCES (2010)
Inflammation and Liver Cancer New Molecular Links
C. Berasain et al.
STEROID ENZYMES AND CANCER (2009)
Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer
Edgar Dahl et al.
BMC CANCER (2009)
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
Valentina Evdokimova et al.
CANCER CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes
Golareh Habibi et al.
BREAST CANCER RESEARCH (2008)
GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation
Nicolas Delcourt et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
被撤回的出版物: Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells(Retracted article. See vol. 230, pg. 1401, 2015)
C Han et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Y-box binding protein 1 - Providing a new angle on translational regulation
Valentina Evdokimova et al.
CELL CYCLE (2006)
Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt
C Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity
P Giménez-Bonafé et al.
PROSTATE (2004)
Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors
R Pai et al.
FASEB JOURNAL (2003)
Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases
KQ Hu
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
The basic and clinical implications of ABC transporters, Y-box-binding protein-1 (YB-1) and angiogenesis-related factors in human malignancies
M Kuwano et al.
CANCER SCIENCE (2003)
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion
M Dohadwala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
